Resmed (RMD) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Resmed (RMD) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 23.94% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -34.15% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.98% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -58.26% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.64% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.33% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -188.83% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 38.46% |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -13.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.98% |
| Mar 31, 2026 | 9.23% |
| Dec 31, 2025 | 13.92% |
| Sep 30, 2025 | 11.94% |
| Jun 30, 2025 | 29.93% |
| Mar 31, 2025 | 21.48% |
| Dec 31, 2024 | 65.05% |
| Sep 30, 2024 | 41.90% |
| Jun 30, 2024 | 27.25% |
| Mar 31, 2024 | 29.24% |
| Dec 31, 2023 | -7.16% |
| Sep 30, 2023 | 4.25% |
| Jun 30, 2023 | 17.74% |
| Mar 31, 2023 | 29.88% |
| Dec 31, 2022 | 11.48% |
| Sep 30, 2022 | 3.37% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | 328.10% |
| Dec 31, 2021 | 12.39% |
| Sep 30, 2021 | 14.15% |